QIMR Berghofer signs strategic partnership with Nakanoshima Qross

With the goal of harnessing their combined medical research expertise to drive improved health outcomes for patients, QIMR Berghofer has signed a strategic partnership agreement with Japanese biomedical innovation hub Nakanoshima Qross.

Nakanoshima Qross (Organisation of Future Medicine) is a unique hub in Osaka, Japan that brings together medical institutions, companies, startups and support organisations to promote the development of cutting-edge ‘future medicine’.

QIMR Berghofer said the agreement marks a strengthening of ties between Queensland and Osaka and will seek opportunities for collaboration on medical research and translation from discovery to the clinic, as well as clinical trials, and joint training and talent exchange initiatives.

“Our internationally recognised research capabilities include expertise across cancer, infectious diseases, brain and mental health, population health, and cell therapy manufacturing,” said Professor Grant Ramm, QIMR Berghofer Interim Director and CEO.

“We are excited to begin working together with Nakanoshima Qross to share knowledge and foster innovation to support our goal of delivering better health and wellbeing globally.”

QIMR Berghofer and Nakanoshima Qross partnership signing ceremony. Source: QIMR Berghofer

Nakanoshima Qross Director Prof. Dr. Yoshiki Sawa said the strategic partnership will reinforce the capabilities of its unique research hubs in diverse areas such oncology, neurology and mental health, as well as cell therapy and regenerative medicine.

“QIMR Berghofer has had a long history of world class research and groundbreaking discoveries in the field of tropical diseases and oncology, and we are excited to be partnering with the Institute. By sharing and combining our complementary expertise, we will accelerate the social implementation of our innovative ideas to solve patients’ current and future medical needs,” Sawa said.

Top image: Professor Grant Ramm and Mr Jun Miyagawa signing the agreement. Source: QIMR Berghofer